Two drugs that interfere with cancer's ability to use testosterone for fuel, apalutamide (Erleada) and enzalutamide (Xtandi), are already approved for use against more advanced prostate tumors that don't respond to regular therapy.
from WebMD Health https://wb.md/2IdVsSW
0 Comments:
Post a Comment